[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)]
- PMID: 32164061
- DOI: 10.3760/cma.j.issn.1007-3418.2020.02.004
[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)]
Keywords: Carcinoma, hepatocellular; Diagnosis; Guidelines; Therapeutics.
Similar articles
-
Advances in Hepatocellular Carcinoma.Clin Liver Dis. 2020 Nov;24(4):xiii-xiv. doi: 10.1016/j.cld.2020.08.014. Clin Liver Dis. 2020. PMID: 33012459 No abstract available.
-
Consensus and controversy in the management of hepatocellular carcinoma.J Am Coll Surg. 2007 Jul;205(1):108-23. doi: 10.1016/j.jamcollsurg.2007.02.025. J Am Coll Surg. 2007. PMID: 17617340 Review. No abstract available.
-
Hepatocellular carcinoma (primary cancer of the liver).Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S57-2S61. Gastroenterol Clin Biol. 2006. PMID: 17151564 Review. No abstract available.
-
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913. Hepatology. 2018. PMID: 29624699 No abstract available.
-
Hepatocellular carcinoma in children.Clin Liver Dis. 2015 May;19(2):433-47. doi: 10.1016/j.cld.2015.01.010. Epub 2015 Feb 28. Clin Liver Dis. 2015. PMID: 25921672 Review.
Cited by
-
The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis.J Hepatocell Carcinoma. 2022 Oct 8;9:1057-1063. doi: 10.2147/JHC.S386977. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 36250136 Free PMC article.
-
Clinical study on conversion therapy of hepatocellular carcinoma - summary and comparison of clinical data from a single center of consecutive four years.BMC Gastroenterol. 2024 Oct 17;24(1):369. doi: 10.1186/s12876-024-03457-8. BMC Gastroenterol. 2024. PMID: 39420264 Free PMC article.
-
Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study.Front Oncol. 2022 Feb 24;12:809709. doi: 10.3389/fonc.2022.809709. eCollection 2022. Front Oncol. 2022. PMID: 35280760 Free PMC article.
-
Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2021 Nov 12;8:1355-1365. doi: 10.2147/JHC.S339707. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34805014 Free PMC article.
-
Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma - 2020 Guangzhou Recommendations.Front Oncol. 2021 Jul 2;11:621834. doi: 10.3389/fonc.2021.621834. eCollection 2021. Front Oncol. 2021. PMID: 34277397 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical